Thimerosal and Autism: A Paradigm for Judges to Act As Gatekeepers

Articles in both legal and scientific journals can foster these unfortunate results. For example, an article titled 'No Longer Immune?' which appeared in the July 2006 issue of the ABA Journal, left the impression that a legitimate debate, both legal and scientific, exists about whether the vaccine preservative, Thimerosal', causes autism. The foundation for the article's controversy about Thimerosal-containing vaccines and autism needs to be challenged and put to rest. In that regard, numerous independent researchers and public health authorities have rejected the theory that an increase in Thimerosal-containing vaccines caused a rapid increase in the rate of autism. Continuing to treat this theory as legitimate and plausible causes fear and confusion among parents and the general public. Resources that are currently being used to pursue illusory proof of this theory should be redirected toward other potentially promising research regarding autism. Shifting the focus off Thimerosal and onto the genetic basis of autism will serve the best interests of children affected by autism and their families. Such a shift will also benefit the scientific and pharmaceutical communities whose resources might better be utilized for more productive research and development.